|
HOME
MAPS
UPDATES
LINKS
HANDOUT
ORDERS
E-MAIL
EYE-OPENERS |
Politics and risks of chemotherapy (11
06 03)
More than $1 TRILLION a year
is spent on medical treatment in America. Over $100 BILLION of
this was spent on cancer treatment. The average cost of cancer
treatment is well over $100,000 per person. This year well over
1.5 million Americans will develop cancer, and over 600, 000
of them will die from it, which means that in the last 5 years
Medical treatment is America's biggest business, representing
over 15% of the entire nation's Gross National Product.
The GAO (General Accounting Office of the United States Government)
has stated in numerous reports that in spite of increased usage
of chemotherapy by medical doctors and hospitals in the treatment
of cancer that they cannot find any statistical data that suggests
it has any effectiveness in prolonging life. The New England
Journal of Medicine reports, War on cancer is a failure: despite
$30 billion spent on research since 1970, cancer remains "undefeated",
with a death rate not lower but actually higher than when they
started. The failure of chemotherapy to control cancer has become
apparent even to the oncology establishment. According to the
PDR (Physicians Desk Reference), the top 10 chemotherapy drugs
used in the USA all list cancer as a side effect. In fact, statistically,
more cancer patients die from chemotherapy treatment than of
the cancer.
Alan C. Nixon, PhD, past president of the American Chemical Society,
wrote, "As a chemist trained to interpret data, it is incomprehensible
to me that physicians can ignore the clear evidence that chemotherapy
does much, much more harm than good." The Los Angeles Times
reported that over 75% of the oncologists polled said that if
they had cancer they would never us e the same chemotherapy they
prescribe for their patients on themselves because of the ineffectiveness
of chemotherapy and its unacceptable degree of toxicity. In 1990
$3.53 billion was spent on chemotherapy and by 1994 that figure
had more than doubled to $7.51 billion.
Why the growth in chemotherapy in the face of such failure? Even
the Federal Government has launched studies into this suggesting
possible corruption. A look at the financial interrelationships
between large cancer centers, for instance Memorial Sloan-Kettering
Cancer Center (MSKCC) considered the finest cancer research center
in the world, and the companies that make billions manufacturing
and selling chemotherapy drugs is revealing. James Robinson III,
Chairman of the MSKCC Board of Overseers and Managers, is also
a director of Bristol-Myers Squibb, the world's largest producer
of chemotherapy drugs. Richard Gelb, Vice-Chairman of the MSKCC
board, is Bristol-Myers Chairman of the Board. Richard Furl,
another MSKCC board member, recently retired as Bristol-Myers'
president. Paul Marks MD, MSKCC's President and CEO, is a director
of Pfizer Pharmaceuticals. John S. Reed, also a chairman at MSKCC,
is also the director of Phillip Morris Tobacco Company. AARP,
the self proclaimed "watchdog" for the elderly, in
the year 2000, received payments of $4 billion from their discount
drug plans and their medical insurance programs.
Dr. Allan Greenberg said on 12/24/2002, "As a retired physician,
I can honestly say that unless you are in a serious accident,
your best chance of living to a ripe old age is to avooid doctors
and hospitals and learn nutrition, herbal medicine and other
forms of ntural medicine. Almost all drugs are toxic and are
designed only to treat symptoms and not to cure anyone. Most
surgery is unnecessary. In short, our mainstream medical system
is hopelessly inept and/or corrupt. The treatment of cancer and
degenerative diseases is a national scandal. The sooner you learn
this, the better off you will be."
|